Medtronic (MDT) Long-Term Deferred Tax (2014 - 2026)

Medtronic (MDT) has 13 years of Long-Term Deferred Tax data on file, last reported at $3.9 billion in Q2 2026.

• For the quarter ending Q2 2026, Long-Term Deferred Tax fell 2.4% year-over-year to $3.9 billion; the trailing twelve-month figure through Apr 2026 stood at $3.9 billion (down 2.4% YoY), and the FY2026 full-year result was $3.9 billion, down 2.4% from the prior year.
• Long-Term Deferred Tax slipped to $3.9 billion in Q2 2026, from $4.0 billion in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $4.0 billion in Q2 2025 to a low of $3.3 billion in Q1 2022.
• A 5-year average of $3.6 billion and a median of $3.6 billion in 2024 frame the typical range for Long-Term Deferred Tax.
• Across the five-year window, Long-Term Deferred Tax grew 10.55% in 2025 and dropped 2.4% in 2026, its largest moves.
• Tracing MDT's Long-Term Deferred Tax over 5 years: stood at $3.4 billion in 2022, then increased by 2.33% to $3.4 billion in 2023, then rose by 4.2% to $3.6 billion in 2024, then gained by 7.98% to $3.9 billion in 2025, then grew by 2.23% to $3.9 billion in 2026.
• Business Quant data shows MDT's Long-Term Deferred Tax at $3.9 billion in Q2 2026, $4.0 billion in Q1 2026, and $3.9 billion in Q4 2025.